{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:38:52Z","timestamp":1787960332608,"version":"build-2784847793"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Alpha-adrenergic antagonist treatment for benign prostatic hyperplasia (BPH) and drug-related sexual side effects are frequent in aging men.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To investigate functional changes in erectile and ejaculatory aspects of male sexuality under Silodosin 8\u00a0mg per day treatment for BPH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Sexually active patients diagnosed with BPH and who initiated Silodosin treatment were the subjects of the study. The International Prostate Symptom Score, premature ejaculation patient profile (PEP-male) questionnaire, Sexual Health Inventory for Men (SHIM) questionnaire, and estimated intravaginal ejaculation latency time (IELT) values of the participants were used to evaluate sexual functions. Data evaluation was performed in 8 urology clinics retrospectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Participant ratings for SHIM, PEP, and estimated IELT were the primary outcome measures in the study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 187 recruited patients, data of 98 patients, who completed the trial period in the study, were eligible. The median age of the eligible participants who completed the trial period for 3\u00a0months was 59.5 years (range 45\u201382). 16 patients of 187 (8%) reported a desire for drug withdrawal for anejaculation during the recruitment period. 46 (46.9%) and 49 (50%) patients reported anejaculation in the first and third month of the treatment, respectively. De novo erectile dysfunction was noticed in 15 patients (15.3%). There was a significant increase in the estimated IELT of subjects in both the first (P\u00a0=\u00a0.01) and third (P\u00a0=\u00a0.002) month. SHIM-1 (P\u00a0=\u00a0.008), SHIM-total (P\u00a0=\u00a0.009), and PEP scores (P\u00a0=\u00a0.008) were also improved in the third month of the treatment. Neither baseline patient characteristics nor changes in the International Prostate Symptom Score after treatment predicted final outcomes with multivariable analysis. The subgroup analysis of participants who reported \u201canejaculation\u201d also revealed better outcomes compared with participants ejaculating naturally in the third month as per SHIM ratings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Despite several male patients having dry orgasms due to Silodosin-induced anejaculation, the majority experienced improved erectile function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths &amp; Limitations<\/jats:title>\n                  <jats:p>The present study demonstrated pioneering results while investigating both erectile and ejaculatory dimensions of the male sexual function during Silodosin treatment for BPH. However, lack of partner evaluation, low follow-up rates, and lack of knowledge about reasons why subjects are lost to follow-up after drug initiation have limited our interpretation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Most patients using Silodosin 8\u00a0mg per day for BPH treatment experienced improvement in their erectile function, estimated IELT, and premature ejaculation profile in the third month of the treatment. Underlying mechanisms and reasons for individual differences necessitate further investigation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2020.02.023","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T20:56:14Z","timestamp":1584996974000},"page":"1094-1100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Changing Aspects of Male Sexual Functions Accompanying Treatment of Benign Prostatic Hyperplasia with Silodosin 8\u00a0mg Per Day"],"prefix":"10.1093","volume":"17","author":[{"name":"\u2018Andrology Study Group of Society of Urologic Surgery-Turkey (SUST)\u2019","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Cihan","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Ni\u011fde , Turkey"},{"name":"Nigde Omer Halisdemir University Research and Training Hospital \u00a0 , Ni\u011fde , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lke Onur","family":"Kazaz","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Trabzon , Turkey"},{"name":"Karadeniz Technical University School of Medicine \u00a0 , Trabzon , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , \u0130stanbul , Turkey"},{"name":"\u0130stanbul University Cerrahpa\u015fa School of Medicine \u00a0 , \u0130stanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Delikta\u015f","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Mu\u011fla , Turkey"},{"name":"Mu\u011fla S\u0131tk\u0131 Ko\u00e7man University School of Medicine \u00a0 , Mu\u011fla , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eakir","family":"Ong\u00fcn","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Bal\u0131kesir , Turkey"},{"name":"Bal\u0131kesir University School of Medicine \u00a0 , Bal\u0131kesir , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmit","family":"G\u00fcl","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Adana , Turkey"},{"name":"Ba\u015fkent University School of Medicine \u00a0 , Adana , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahad\u0131r","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , \u0130stanbul , Turkey"},{"name":"\u0130stanbul Pendik Research and Training Hospital \u00a0 , \u0130stanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130yimser","family":"\u00dcre","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Eski\u015fehir , Turkey"},{"name":"Osmangazi University School of Medicine \u00a0 , Eski\u015fehir , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdi","family":"\u00d6zkara","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , \u0130stanbul , Turkey"},{"name":"\u0130stanbul University Cerrahpa\u015fa School of Medicine \u00a0 , \u0130stanbul , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"2023011111085595400_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0035-1565100","article-title":"Sexual dysfunction related to drugs: a critical review. Part V: \u03b1-blocker and 5-ARI drugs","volume":"49","author":"Torre","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"2023011111085595400_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.urology.2008.06.048","article-title":"Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment","volume":"74","author":"Hellstrom","year":"2009","journal-title":"Urology"},{"key":"2023011111085595400_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/iju.13088","article-title":"Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: a European phase IV clinical study (SiRE study)","volume":"23","author":"Montorsi","year":"2016","journal-title":"Int J Urol"},{"key":"2023011111085595400_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00345-015-1519-2","article-title":"Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH","volume":"33","author":"Osman","year":"2015","journal-title":"World J Urol"},{"key":"2023011111085595400_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1464-410X.2006.06448.x","article-title":"Silodosin, a new \u03b11A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men","volume":"98","author":"Kawabe","year":"2006","journal-title":"BJU Int"},{"key":"2023011111085595400_bib6","first-page":"1554","article-title":"Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis","volume":"11","author":"Gacci","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"2023011111085595400_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","article-title":"Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe","volume":"59","author":"Chapple","year":"2011","journal-title":"Eur Urol"},{"key":"2023011111085595400_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ijir.2009.27","article-title":"Orgasm is preserved regardless of ejaculatory dysfunction with selective \u03b11A-blocker administration","volume":"21","author":"Kobayashi","year":"2009","journal-title":"Int J Impot Res"},{"key":"2023011111085595400_bib9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/bju.12906","article-title":"Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data","volume":"115","author":"Novara","year":"2015","journal-title":"BJU Int"},{"key":"2023011111085595400_bib10","first-page":"1277","article-title":"Impact of dry ejaculation caused by highly selective alpha1A-blocker: randomized, double-blind, placebo-controlled crossover pilot study in healthy volunteer men","volume":"7","author":"Shimizu","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2023011111085595400_bib11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/andr.12095","article-title":"Effects of silodosin on sexual function - realistic picture from the everyday clinical practice","volume":"3","author":"Capogrosso","year":"2015","journal-title":"Andrology"},{"key":"2023011111085595400_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/pcan.2010.46","article-title":"Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH","volume":"14","author":"Roehrborn","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2023011111085595400_bib13","first-page":"2634","article-title":"Rapid efficacy of the highly selective \u03b11A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies","volume":"181","author":"Marks","year":"2009","journal-title":"J\u00a0Urol"},{"key":"2023011111085595400_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/iju.12915","article-title":"Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?","volume":"22","author":"Yamanishi","year":"2015","journal-title":"Int J Urol"},{"key":"2023011111085595400_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.urology.2015.01.011","article-title":"Silodosin causes impaired ejaculation and enlargement of seminal vesicles in sexually active men treated for lower urinary tract symptoms suggestive of benign prostatic hyperplasia","volume":"85","author":"Bozkurt","year":"2015","journal-title":"Urology"},{"key":"2023011111085595400_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.urology.2017.08.025","article-title":"A\u00a0prospective study to evaluate sexual dysfunction and enlargement of seminal vesicles in sexually active men treated for benign prostatic hyperplasia by alpha-blockers","volume":"118","author":"Sokhal","year":"2018","journal-title":"Urology"},{"key":"2023011111085595400_bib17","first-page":"2185","article-title":"Inhibition of seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers","volume":"5","author":"Kobayashi","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"2023011111085595400_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/luts.12072","article-title":"Effects of silodosin and tamsulosin on the seminal vesicle contractile response","volume":"8","author":"Hayashi","year":"2016","journal-title":"Low Urin Tract Symptoms"},{"key":"2023011111085595400_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","article-title":"Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"60","author":"Gacci","year":"2011","journal-title":"Eur Urol"},{"key":"2023011111085595400_bib20","first-page":"1059","article-title":"Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners","volume":"177","author":"Rosen","year":"2007","journal-title":"J\u00a0Urol"},{"key":"2023011111085595400_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"2023011111085595400_bib22","first-page":"45","article-title":"The assessment of Turkish validation with 5 question version of International Index of Erectile Function (IIEF-5)","volume":"33","author":"Turun\u00e7","year":"2007","journal-title":"Turk J Urol"},{"key":"2023011111085595400_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract\u00a0symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"key":"2023011111085595400_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5152\/tud.2017.24886","article-title":"Prevalence of erectile dysfunction in men over 40 years of age in Turkey: results from the Turkish Society of Andrology Male Sexual Health Study Group","volume":"43","author":"\u00c7ayan","year":"2017","journal-title":"Turk J Urol"},{"key":"2023011111085595400_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0302-2838(02)00027-1","article-title":"Prevalence and correlates of erectile dysfunction in Turkey: a population-based study","volume":"41","author":"Akkus","year":"2002","journal-title":"Eur Urol"},{"key":"2023011111085595400_bib26","first-page":"705","article-title":"The relationship between self-estimated intravaginal ejaculatory latency time and international prostate symptom score in middle-aged men complaining of ejaculating prematurely in china","volume":"12","author":"Zhang","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"2023011111085595400_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1442-2042.2010.02708.x","article-title":"Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia","volume":"18","author":"Yokoyama","year":"2011","journal-title":"Int J Urol"},{"key":"2023011111085595400_bib28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/nau.23015","article-title":"Effects of silodosin, a selective alpha-1A adrenoceptor antagonist, on erectile function in a rat model of partial bladder outlet obstruction","volume":"36","author":"Bastask\u0131n","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"2023011111085595400_bib29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/iju.13392","article-title":"Silodosin versus naftopidil in the treatment of premature ejaculation: a prospective multicenter trial","volume":"24","author":"Sato","year":"2017","journal-title":"Int J Urol"},{"key":"2023011111085595400_bib30","doi-asserted-by":"crossref","first-page":"e13805","DOI":"10.5812\/ircmj.13805","article-title":"Comparison of alpha blockers in treatment of premature ejaculation: a pilot clinical trial","volume":"15","author":"Akin","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"2023011111085595400_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1569-9056(08)60391-7","article-title":"Sexual function and opinion of patients treated for the first time for LUTS\/BPH (abstract)","volume":"7","author":"Fourcade","year":"2008","journal-title":"Eur Urol Suppl"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609520301284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609520301284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/17\/6\/1094\/48527070\/jsm_17_6_1094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/17\/6\/1094\/48527070\/jsm_17_6_1094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T14:44:23Z","timestamp":1675953863000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/17\/6\/1094\/6973782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,3,23]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2020.02.023","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing Aspects of Male Sexual Functions Accompanying Treatment of Benign Prostatic Hyperplasia With Silodosin 8\u00a0mg Per Day","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2020.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}